Announcements Trials
Browse Landscape

Phase

Phase 1 16Phase 2 9Phase NA 6Phase 1/2 5Phase 3 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2

Conditions

Stomatitis 1Neoplasms 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 361Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT00472043 2024-08-06

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma

Galderma R&D

Phase 3 Completed
66 enrolled 15 charts
Dermatologic

Carcinoma, Basal Cell

NCT01966120 2023-07-28

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Biofrontera Bioscience GmbH

Phase 3 Completed
87 enrolled 21 charts
Dermatologic

Keratosis, Actinic

NCT02555501 2015-09-21

OMLTPT

Universidade Ceuma

Phase 3 Completed
18 enrolled

Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡